{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:50:20Z","timestamp":1780473020620,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s11882-004-0010-8","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T22:16:28Z","timestamp":1180822588000},"page":"447-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Update on side effects from common vaccines"],"prefix":"10.1007","volume":"4","author":[{"given":"Benjamin J.","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit K.","family":"Katial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1078-5337(03)00053-4","volume":"10","author":"NC Ales","year":"2004","unstructured":"Ales NC, Katial RK: Vaccines against biologic agents: uses and development. Respir Care Clin North Am 2004, 10:123\u2013146. d review on various formulations of vaccines directed against the category A agents responsible for bioterrorism.","journal-title":"Respir Care Clin North Am"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0889-8561(03)00090-0","volume":"23","author":"RM Jacobson","year":"2003","unstructured":"Jacobson RM: Vaccine safety. Immunol Allergy Clin North Am 2003, 23:589\u2013603.","journal-title":"Immunol Allergy Clin North Am"},{"key":"10_CR3","first-page":"1","volume":"52","author":"W Zhou","year":"2003","unstructured":"Zhou W, Pool V, Iskander JK, et al.: Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001. MMWR Morbid Mortal Wkly Rep 2003, 52:1\u201324. etrospective study of adverse events reported to VAERS during the past decade show that the most common reports were self-limited and localized to the injection site.","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/thorax.58.10.835","volume":"58","author":"LJ Tata","year":"2003","unstructured":"Tata LJ, West J, Farrington P, et al.: Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003, 58:835\u2013839.","journal-title":"Thorax"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al.: Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. American Journal of Epidemiology 1979, 110:105\u2013123.","journal-title":"American Journal of Epidemiology"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S1521-6616(03)00046-9","volume":"107","author":"MR Geier","year":"2003","unstructured":"Geier MR, Geier DA, Zahalsky AC: Influenza vaccination and Guillain Barre Syndrome. Clin Immunol 2003, 107:116\u2013121. following influenza vaccination was shown by review of VAERS; in addition, endotoxin levels were measured and found to vary significantly and potentially partially account for adverse events.","journal-title":"Clin Immunol"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0022-510X(98)00139-7","volume":"159","author":"J DeKeyser","year":"1998","unstructured":"DeKeyser J, Zwanikken C, Boon M: Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 1998, 159:51\u201353.","journal-title":"J Neurol Sci"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","volume":"350","author":"M Mutsch","year":"2004","unstructured":"Mutsch M, Zhou W, Rhodes P, et al.: Use of inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland. N Engl J Med 2004, 350:896\u2013903.","journal-title":"N Engl J Med"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0264-410X(03)00095-1","volume":"21","author":"G e Serres","year":"2003","unstructured":"e SerresG, Boulianne N, Duval B, et al.: Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine. Vaccine 2003, 21:2346\u20132353.","journal-title":"Vaccine"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/S0264-410X(03)00094-X","volume":"21","author":"G De Serres","year":"2003","unstructured":"De Serres G, Grenier JL, Toth E, et al.: The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination. Vaccine 2003, 21:2354\u20132361.","journal-title":"Vaccine"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1067\/S0022-3476(03)00536-5","volume":"143","author":"WA Jastaniah","year":"2003","unstructured":"Jastaniah WA, Dobson S, Lugsdin JG, Petty RE: Complex regional pain syndrome after hepatitis B vaccine. J Pediatr 2003, 143:802\u2013804.","journal-title":"J Pediatr"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1517\/14740338.2.3.225","volume":"2","author":"P Duclos","year":"2003","unstructured":"Duclos P: Safety of immunization and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf 2003, 2:225\u2013231.","journal-title":"Expert Opin Drug Saf"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","volume":"55","author":"C Black","year":"2003","unstructured":"Black C, Kaye JA, Jick H: MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol 2003, 55:107\u2013111.","journal-title":"Br J Clin Pharmacol"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00006454-200302000-00006","volume":"22","author":"T Jadavji","year":"2003","unstructured":"Jadavji T, Scheiflele D, Halperin S: Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J 2003, 22:119\u2013122.","journal-title":"Pediatr Infect Dis J"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/aje\/kwf167","volume":"157","author":"M Ki","year":"2003","unstructured":"Ki M, Park T, Yi SG, et al.: Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design. Am J Epidemiol 2003, 157:158\u2013165. ng a cross-over design, the side effects of MMR-related aseptic meningitis were determined to be dependent upon the strain of virus used to produce the vaccine.","journal-title":"Am J Epidemiol"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","volume":"112","author":"N LeSaux","year":"2003","unstructured":"LeSaux N, Barrowman NJ, Moore DL, et al.: Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics 2003, 112:e348\u2013353. After switching from DTwP to DTaP, rates of seizures and hypotonichyporesponsive episodes declined, whereas rates remained unchanged following MMR vaccination.","journal-title":"Pediatrics"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","volume":"351","author":"AJ Wakefield","year":"1998","unstructured":"Wakefield AJ, Murch SH, Anthony A, et al.: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998, 351:637\u2013641.","journal-title":"Lancet"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/bmj.322.7284.460","volume":"322","author":"JA Kaye","year":"2001","unstructured":"Kaye JA: Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001, 322:460\u2013463.","journal-title":"BMJ"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.285.9.1183","volume":"285","author":"L Dales","year":"2001","unstructured":"Dales L, Hammer SJ, Smith NJ: Time trends in autism and in MMR immunization coverage in California. J Am Med Assoc 2001, 285:1183\u20131185.","journal-title":"J Am Med Assoc"},{"key":"10_CR20","first-page":"5741","volume":"164","author":"KM Madsen","year":"2003","unstructured":"Madsen KM, Hviid A, Vertergaard M, et al.: MMR vaccination and autism\u2014a population-based follow-up study. Ugeskr Laeger 2003, 164:5741\u20135744.","journal-title":"Ugeskr Laeger"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(99)01239-8","volume":"353","author":"B Taylor","year":"1999","unstructured":"Taylor B, Miller E, Farrington CP, et al.: Autism and measles, mumps, and rubella vaccine: no epidemiologic evidence for a causal association. Lancet 1999, 353:2026\u20132029.","journal-title":"Lancet"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/bmj.324.7334.393","volume":"324","author":"B Taylor","year":"2002","unstructured":"Taylor B, Miller E, Lingam R, et al.: Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002, 324:393\u2013396.","journal-title":"BMJ"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/archpedi.157.7.628","volume":"157","author":"K Wilson","year":"2003","unstructured":"Wilson K, Mills E, Ross C, et al.: Association of autistic spectrum disorder and the measles, mumps and rubella vaccine. Arch Pediatr Adolesc Med 2003, 157:628\u2013634. Systematic review of literature does not support an association between MMR and autism, although epidemiologic studies make ruling out a rare variant of ASD difficult. Studies consistently show no increase in MMR vaccination rates to account for the increased autism rates and, furthermore, no temporal correlation of autism with age of MMR administration.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1542\/peds.108.4.e58","volume":"108","author":"E Fombonne","year":"2001","unstructured":"Fombonne E, Chakrabarti S: No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001, 108:e58\u201364.","journal-title":"Pediatrics"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/adc.87.6.493","volume":"87","author":"N Andrews","year":"2002","unstructured":"Andrews N, Miller E, Taylor B, et al.: Recall bias, MMR and autism. Arch Dis Child 2002, 87:493\u2013494. Findings of this study demonstrate the phenomenon of recall bias that is likely playing a significant role in the propagation of the purported link between MMR and autism.","journal-title":"Arch Dis Child"},{"key":"10_CR26","unstructured":"The National Academies: Immunization Safety Review: vaccines and autism. http:\/\/www4.nationalacademies.org\/news.nsf\/isbn\/ s030909237X? OpenDocument. Accessed June 1, 2004."},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/S0264-410X(03)00173-7","volume":"21","author":"SA Halperin","year":"2003","unstructured":"Halperin SA, Scheifele D, Mills E, et al.: Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. Vaccine 2003, 21:2298\u20132306.","journal-title":"Vaccine"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1086\/375820","volume":"37","author":"EJ Woo","year":"2003","unstructured":"Woo EJ, Burwen DR, Gatumu SNM, Ball R: Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system. Clin Infect Dis 2003, 37:351\u2013358.","journal-title":"Clin Infect Dis"},{"key":"10_CR29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.68.5.650","volume":"68","author":"CL Cody","year":"1981","unstructured":"Cody CL, Baraff LJ, Cherry JD, et al.: Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981, 68:650\u2013659.","journal-title":"Pediatrics"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1542\/peds.106.4.e52","volume":"106","author":"TS DuVernoy","year":"2000","unstructured":"DuVernoy TS, Braun MM: Hypotonic-hyporesponsive episodes reported to the vaccine adverse event reporting system (VAERS), 1996\u20131998. Pediatrics 2000, 106:e52-e61.","journal-title":"Pediatrics"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1081-1206(10)62148-5","volume":"90","author":"C Mayorga","year":"2003","unstructured":"Mayorga C, Torres MJ, Corzo JL, et al.: Immediate allergy to tetanus vaccine: determination of immunoglobulin E and immunoglobulin G antibodies to allergenic proteins. Ann Allergy Asthma Immunol 2003, 90:238\u2013243.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/jnci\/95.7.532","volume":"95","author":"EA Engels","year":"2003","unstructured":"Engels EA, Katki HA, Nielsen NM, et al.: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003, 95:532\u2013539.","journal-title":"J Natl Cancer Inst"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1196\/annals.1288.068","volume":"1005","author":"J Wahlberg","year":"2003","unstructured":"Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J: Vaccinations may induce diabetes-related autoantibodies in one-year-old children. Ann N Y Acad Sci 2003, 1005:404\u2013408.","journal-title":"Ann N Y Acad Sci"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1086\/374420","volume":"187","author":"TV Murphy","year":"2003","unstructured":"Murphy TV, Smith PJ, Gargiullo PM, Schwartz B: The first rotavirus vaccine and intussusception epidemiological studies and policy decisions. J Infect Dis 2003, 187:1309\u20131313. The discovery of increased intussusception rate following rotavirus vaccination is examined. Although review of the literature suggests a slightly lower than reported rate, the absolute increase was deemed unacceptable.","journal-title":"J Infect Dis"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1086\/378504","volume":"188","author":"A Gershon","year":"2003","unstructured":"Gershon A: Varicella vaccine: rare serious problems\u2014but the benefits still outweigh the risks. J Infect Dis 2003, 188:945\u2013947.","journal-title":"J Infect Dis"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1542\/peds.112.6.1394","volume":"112","author":"PA Offit","year":"2003","unstructured":"Offit PA, Jew RK: Addressing parents\u2019 concerns: Do vaccines contain harmful preservatives, adjuvants, additives or residuals? Pediatrics 2003, 112:1394\u20131401. The concept of vaccine constituents is addressed and includes discussion of preservatives, adjuvants, additives, and residuals\/AE.","journal-title":"Pediatrics"},{"key":"10_CR37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/153537020322800603","volume":"228","author":"MR Geier","year":"2003","unstructured":"Geier MR, Geier DA: Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exper Biol Med 2003, 228:660\u2013664.","journal-title":"Exper Biol Med"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.290.13.1763","volume":"290","author":"A Hviid","year":"2003","unstructured":"Hviid A, Stellfeld M, Wohlfahrt J, Melbye M: Association between thimerosal-containing vaccine and autism. JAMA 2003, 290:1763\u20131766.","journal-title":"JAMA"},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0749-3797(03)00113-2","volume":"25","author":"P Stehr-Green","year":"2003","unstructured":"Stehr-Green P, Tull P, Stellfeld M, et al.: Autism and thimerosalcontaining vaccines: lack of consistent evidence for an association. Am J Prevent Med 2003, 25:101\u2013106. In a study involving three countries, rates of autism increase could not be accounted for by increased exposure to thimerosal.","journal-title":"Am J Prevent Med"},{"key":"10_CR40","first-page":"77","volume":"32","author":"J Grabestein","year":"1997","unstructured":"Grabestein J, Pharm MS: Clinical management of hypersensitivities to vaccine components. Hosp Pharm 1997, 32:77\u201378.","journal-title":"Hosp Pharm"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1473-3099(04)00927-2","volume":"4","author":"T Jefferson","year":"2004","unstructured":"Jefferson T, Rudin M, DiPietrantonj C: Adverse events after immunization with aluminum-containing DTP vaccines: systematic review of evidence. Lancet Infect Dis 2004, 4:84\u201390.","journal-title":"Lancet Infect Dis"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1067\/mai.2002.129372","volume":"110","author":"RS Zeiger","year":"2002","unstructured":"Zeiger RS: Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 2002, 110:834\u2013840. The interaction between egg allergy and influenza vaccine is reviewed. Even in egg allergic patients, influenza vaccination is safe to administer in a two-dose, graded regimen if the egg content is <1.2 \u03bcg\/dose.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0010-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-004-0010-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0010-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0010-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:19:02Z","timestamp":1659089942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-004-0010-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1007\/s11882-004-0010-8","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}